• Putting Cramer in Context Friday, 15 Aug 2008 | 7:18 PM ET

    This is how you balance Mad Money stock picks with your own portfolio.

  • Speculating on Alexion Pharma Thursday, 14 Aug 2008 | 11:44 PM ET

    This biotech sells its treatment to a niche clientele for big money.

  • Worst House, Best Neighborhood Wednesday, 13 Aug 2008 | 11:09 PM ET

    Vertex Pharma is lagging its peers. But biotech is so good right now, it might not matter.

  • Cramer's Latest Biotech Buy Wednesday, 13 Aug 2008 | 1:33 AM ET

    Genzyme may make orphan drugs, but this company is a lot closer to Daddy Warbucks.

  • Buy Biotech Monday, 11 Aug 2008 | 11:38 PM ET

    Cramer offers up five reasons why this sector is the best one to own through the fall. Plus, the top stocks in the group.

  • Oil Is All That Matters Tuesday, 22 Jul 2008 | 6:26 PM ET

    Why's the market up after such horrible earnings? Black gold, that's why.

  • Who's Next After Genentech? Monday, 21 Jul 2008 | 7:06 PM ET

    Cramer ventures a guess as to who's next on the takeover list.

  • Boston Scientific quarterly earnings fell 15 percent on declining sales of its drug-eluting stents and charges for acquisitions, divestitures and restructuring.

  • Game Plan: What to do with Fannie and Freddie Friday, 11 Jul 2008 | 6:37 PM ET

    Also, how to play next week's busy schedule of earnings.

  • Eli Lilly to Buy SGX Pharmaceuticals for $64 Million Tuesday, 8 Jul 2008 | 6:52 PM ET

    Drug developer Eli Lilly will buy SGX Pharmaceuticals for about $64 million in cash in an effort to expand its drug discovery efforts, the companies said Tuesday.

  • Win With Genentech Against the Bears Monday, 7 Jul 2008 | 11:18 PM ET

    Cramer continued with his "Cramerican Marine Field Guide to Recessions" reflecting on the 1990 Playbook (the last time we had a financial meltdown) where healthcare stocks, especially biotech were the winners then, and in Cramer's view are likely to do it again.

  • How to Play the Recession Game Monday, 7 Jul 2008 | 7:25 PM ET

    Cramer tells what works in the Wall Street fashion show, what gets the big money guys to turn their heads and say, “ah, I want to own that right now,” or "I want to dump that right now", for the exact  situation we’re facing.

  • Stop Trading!: Buy Biotech? Monday, 30 Jun 2008 | 3:22 PM ET

    That's what worked in 1990, in an environment much like this one.

  • Liposuction Without the Surgery Friday, 20 Jun 2008 | 6:31 PM ET

    Medicis Pharma could have such a product on the market by 2011.

  • Stop Trading!: Buy Yum! Brands Thursday, 5 Jun 2008 | 3:28 PM ET

    Plus, two more international stock picks from Cramer.

  • Antigenics Finds That "Russian Roulette" Pays Off Tuesday, 8 Apr 2008 | 10:31 AM ET

    This morning a little biotech company, Antigenics, announced that Russia has approved its kidney cancer drug Oncophage. It's the first so-called therapeutic cancer vaccine to win full-out approval anywhere in the world.

  • Lightning Round: Celgene, Apple, Chevron and More Tuesday, 25 Mar 2008 | 7:09 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Lightning Round: Medco, Amgen, Yum! and More Thursday, 28 Feb 2008 | 8:12 PM ET

    Cramer makes the call on viewers' favorite stocks.

  • Fund Manager: Buy Fast -- and Buy These Names Tuesday, 26 Feb 2008 | 3:29 PM ET

    The time to buy stocks, says Michael Cuggino, is now. The president and portfolio manager of Permanent Portfolio Funds offered CNBC very specific reasons to buy -- and the specific stocks you need.

  • Lightning Round: Loews, NYSE, Tesco and More Tuesday, 15 Jan 2008 | 3:39 PM ET

    Cramer makes the call on viewers' favorite stocks.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

Most Popular Video

Wednesday, 23 Apr 2014 | 12:32 AM ET

Eddie Tam, CIO at Central Asset Investments, says China will see a slowdown for a long time as a trade-off for avoiding a hard landing in its economy.

Tuesday, 22 Apr 2014 | 10:48 PM ET

Todd Elmer, Currency Strategist at Citi, discusses whether the currency's sharp drop following weaker-than-expected quarterly inflation data was justified.

Tuesday, 22 Apr 2014 | 10:30 PM ET

Adaire Fox-Martin, COO, Asia Pacific Japan at SAP, elaborates on the firm's "stunning results" in Southeast Asia, India and the sector of cloud computing in the first-quarter.